The Preventable Peptide Crisis: Navigating GLP-1s and the Gray Market
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
The Preventable Peptide Crisis: Navigating GLP-1s and the Gray Market
-
Letto da:
-
Di:
In this episode of the Health Policy Podcast, host Brian Hyde speaks with Peter Pitts, former FDA Associate Commissioner and President of the Center for Medicine in the Public Interest. They discuss the growing popularity of GLP-1 weight loss drugs and the critical issues surrounding their use. Pitts emphasizes that while GLP-1s can be effective, they are not a "magic pill" and should be used under medical supervision, alongside diet and exercise, and not for chronic conditions without further research. The conversation highlights the serious dangers posed by counterfeit and unapproved GLP-1s sold online, stressing the lack of quality control and the potential for severe health consequences, including hospitalization and death. Pitts advocates for increased FDA enforcement against these criminal enterprises and advises consumers on how to avoid falling victim to illicit suppliers, emphasizing the importance of FDA approval and doctor consultation.